Skin cancer announces itself through visible changes on the skin, but the specific warning signs depend on the type of cancer, where it grows, and even the age and skin tone of the person affected. The classic checklist most people have heard of, the ABCDE rule for melanoma, catches a large share of cases but misses enough to be dangerous on its own. Some skin cancers show up as pearly bumps, others as red patches that won’t heal, and a troubling minority look like nothing more than a pale pink spot or a small blister that bleeds.
The ABCDE Rule and What It Actually Catches
The most widely taught screening tool for melanoma is the ABCDE checklist: Asymmetry, Border irregularity, Color variation, Diameter greater than about 6 mm, and Evolution (any change over time). Dermatologists have used it for decades because it captures features common to many melanomas, particularly the superficial spreading type that accounts for the majority of cases. A systematic review of studies validating the ABCDE rule found that it achieved a sensitivity of about 84% and specificity of about 78% in one of the better-documented evaluations, meaning it correctly flagged most melanomas while also incorrectly flagging some benign moles.1PubMed Central. Diagnosing malignant melanoma in ambulatory care: a systematic review of clinical prediction rules
Those numbers are decent but far from perfect. Roughly one in six melanomas slips past the ABCDE criteria. Many of those missed cases are nodular melanomas, which tend to be symmetrical and uniform in color during their early growth. Others are amelanotic melanomas, which lack the dark pigmentation most people associate with skin cancer. And in children, more than half of melanomas don’t match the classic ABCDE pattern at all, a problem significant enough that researchers have proposed an entirely different checklist for younger patients.
The Ugly Duckling Sign
A complementary approach that dermatologists increasingly rely on is the “ugly duckling” sign. Instead of evaluating a single mole against an abstract checklist, you compare each mole to the others around it. Most people have a dominant mole pattern: their spots tend to share a similar size, color, and shape. A mole that stands out from its neighbors, looking noticeably different from the rest, is the ugly duckling. In a study of over 2,000 clinical images from 80 patients, every single melanoma was identified as an ugly duckling by the dermatologists reviewing the photos.2PubMed. Ugly Duckling Sign as a Major Factor of Efficiency in Melanoma Detection A separate study found that the ugly duckling sign had a sensitivity of 90% across all observer groups, including non-clinicians, suggesting that even people without medical training can learn to spot an outlier mole.3JAMA Dermatology. The “Ugly Duckling” Sign: Agreement Between Observers
The practical takeaway is that the ABCDE rule and the ugly duckling sign work best together. The ABCDE criteria tell you what to look for in a single lesion. The ugly duckling sign tells you which lesion to look at in the first place. When researchers combined both approaches in one study, the number of moles flagged for possible biopsy dropped nearly sevenfold compared with evaluating each mole individually, without missing any melanomas.2PubMed. Ugly Duckling Sign as a Major Factor of Efficiency in Melanoma Detection
What Basal Cell and Squamous Cell Carcinomas Look Like
Melanoma gets the most attention, but basal cell carcinoma (BCC) is the most common cancer in humans, period.4PubMed. Basal cell carcinoma: Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations It typically appears on sun-exposed areas like the face, ears, and scalp. The classic BCC looks like a pearly or waxy bump, sometimes with visible tiny blood vessels running through it. It can also show up as a flat, flesh-colored or brown scar-like patch. BCCs rarely spread to distant parts of the body, but they burrow into surrounding tissue if left untreated and can become disfiguring, especially around the nose and eyes.
Squamous cell carcinoma (SCC) is the second most common skin cancer and often begins as a rough, scaly patch called an actinic keratosis. These precancerous patches feel like sandpaper and appear on chronically sun-exposed areas: the backs of hands, forearms, face, ears, and bald scalp. Not every actinic keratosis becomes cancer. Many persist unchanged or even fade on their own. But because doctors cannot predict which individual patches will progress, the recommendation is to monitor and treat all of them.5PubMed. From actinic keratosis to squamous cell carcinoma: pathophysiology revisited When SCC does develop, it usually appears as a firm, red nodule or a flat lesion with a crusty surface. Unlike BCC, SCC carries a meaningful risk of spreading to lymph nodes and other organs if diagnosis is delayed.
A useful rule of thumb: any sore on sun-exposed skin that doesn’t heal within a few weeks, or that heals and then reopens, deserves a professional look. That non-healing quality is one of the most reliable everyday signals for both BCC and SCC.
When Skin Cancer Lacks Color
One of the most dangerous misconceptions about skin cancer is that it always involves a dark or oddly colored spot. Amelanotic melanomas produce little or no pigment, meaning they can appear pink, red, or even skin-colored. These lesions frequently get mistaken for bug bites, scratches, or minor irritations. In one large database study, red amelanotic melanomas made up about 4% of all melanomas and roughly 70% of all amelanotic melanomas. Melanoma was included in the doctor’s initial list of suspected diagnoses only 32% of the time for these lesions, compared with 94% for pigmented melanomas.6PubMed Central. Amelanotic Melanomas Presenting as Red Skin Lesions: A Diagnostic Challenge with Potentially Lethal Consequences
That diagnostic delay matters. Red amelanotic melanomas were far more likely to undergo a shave biopsy (a shallow sample) rather than a deeper excision, and more than a third had cancer cells at the deep biopsy margins, compared with about 9% for pigmented melanomas.6PubMed Central. Amelanotic Melanomas Presenting as Red Skin Lesions: A Diagnostic Challenge with Potentially Lethal Consequences On dermoscopy, a handheld magnification device, these unpigmented melanomas tend to show white structureless zones and unusual blood vessel patterns rather than the dark network typical of pigmented lesions.7PubMed. Clinicopathological and dermoscopic features of amelanotic and hypomelanotic melanoma: a retrospective multicentric study The bottom line for self-checks: if a new pink or red bump persists for more than a few weeks and you can’t explain it, bring it to a dermatologist. Waiting for something to “look like skin cancer” by turning dark can cost you valuable time.
Warning Signs in Darker Skin Tones
Skin cancer is less common in people with more melanin, but when it occurs, it behaves differently and is often diagnosed later. In people of color, skin cancer frequently shows up in places that get little sun exposure: the soles of the feet, the palms of the hands, underneath fingernails and toenails, and on the hips and lower legs.8PubMed Central. Skin Cancer Concerns in People of Color: Risk Factors and Prevention The most characteristic type is acral lentiginous melanoma (ALM), which arises on the palms, soles, and nail beds.
On the sole of the foot, ALM can look like a dark, irregularly shaped patch or a streak of pigment along a toenail. Under dermoscopy, a pattern called the parallel ridge pattern, where pigment follows the ridges of fingerprint-like skin markings, is a key diagnostic clue.9PubMed Central. Race-Specific and Skin of Color Dermatoscopic Characteristics of Skin Cancer: A Literature Review But you don’t need a dermoscope to notice a new dark spot on the sole of your foot or a dark streak under a nail that wasn’t there before, especially one that widens or extends into the surrounding skin.
Late diagnosis is a serious problem. Five-year survival rates for ALM are substantially lower in Black patients (about 67%) and Hispanic White patients (about 72%) compared with non-Hispanic White patients (about 84%), and that gap persists even after accounting for disease stage at diagnosis.10Clinical and Experimental Dermatology. Understanding acral lentiginous melanoma: from the clinic to guidelines Part of the survival difference comes from tumors being thicker and more advanced by the time they are found. The pattern is clear: because both patients and doctors may not be looking for skin cancer on darker skin, these cancers grow undetected for longer.
Skin Cancer in Children and Teens
Pediatric melanoma is rare, but when it does occur, it looks different enough from adult melanoma that the standard ABCDE checklist can be actively misleading. In a large cohort study, 60% of children under 10 with melanoma did not present with conventional ABCDE features.11PubMed. Pediatric melanoma: results of a large cohort study and proposal for modified ABCD detection criteria for children Instead, the most common signs were amelanotic (non-pigmented) lesions, bleeding or raised bumps, uniform color, and development on previously normal skin rather than within an existing mole.12PubMed Central. Pediatric melanoma: incidence, treatment, and prognosis
Researchers have proposed a modified set of criteria to fill this gap: Amelanotic, Bleeding or Bump, Color uniformity, De novo development or any Diameter, and Evolution. In younger children, the key red flag is any skin lesion that is changing, even if it doesn’t look dark or irregular.13PubMed. Paediatric melanoma A pink bump that bleeds on a child’s skin is far more suspicious than it would seem to a parent scanning for dark, oddly shaped moles. If your child has a lesion that keeps changing, bleeding, or growing, have a pediatric dermatologist evaluate it regardless of whether it matches what adult melanoma “should” look like.
Melanoma in Hidden Locations
Not all melanoma starts on the outer skin. Mucosal melanomas arise on the mucous membranes inside the body: the nasal passages, sinuses, mouth, throat, vulva, vagina, rectum, and urinary tract. These account for a small fraction of all melanomas, but their prognosis is grim. The overall five-year survival sits around 25%, largely because the tumors grow in places that are hard to see and don’t cause symptoms until they’re advanced.14PubMed. Primary mucosal melanoma
The most common location is the head and neck region, particularly inside the nasal cavity and sinuses, accounting for over half of mucosal melanomas. Female genital tract and anorectal sites make up most of the remainder.14PubMed. Primary mucosal melanoma Symptoms depend on the site: persistent nosebleeds or nasal congestion on one side, unexplained vaginal bleeding, or rectal bleeding that’s attributed to hemorrhoids but doesn’t resolve. Adding to the diagnostic challenge, mucosal melanomas are often amelanotic, lacking the dark pigment that would otherwise raise suspicion.15The Oncologist. Mucosal Melanomas: A Case-Based Review of the Literature Roughly a third of patients already have lymph node involvement by the time the cancer is found.14PubMed. Primary mucosal melanoma
This isn’t something to obsess over during every head cold, but any persistent, unexplained mucosal symptom, especially one-sided nasal symptoms or bleeding from the gums, rectum, or genitals that doesn’t match an obvious benign cause, warrants medical evaluation.
Merkel Cell Carcinoma and Other Uncommon Types
Merkel cell carcinoma (MCC) is rare but aggressive, and it has its own distinctive pattern. Researchers have summarized its typical presentation with the acronym AEIOU: Asymptomatic (not tender or painful), Expanding rapidly, Immune suppression in the patient’s history, Older than 50, and on an Ultraviolet-exposed site in a person with fair skin. In a study of 195 patients, 89% of primary Merkel cell carcinomas had three or more of these features.16PubMed Central. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features
The visual appearance is a firm, dome-shaped, painless nodule, often red or violet. It grows noticeably over weeks to months, which is a critical distinguishing feature. A lump that doubles in size within a month or two, particularly in someone who is immunosuppressed (organ transplant recipients, people on long-term immunosuppressive medications, those with certain blood cancers), should be biopsied without delay. Organ transplant recipients face an especially elevated risk because immunosuppressive drugs not only weaken immune surveillance against cancer cells but also impair the skin cells’ ability to repair DNA damage from ultraviolet light.17PubMed Central. Skin cancer in organ transplant recipients: more than the immune system
What Advanced Skin Cancer Feels Like
Early-stage skin cancers are usually painless. That changes as disease progresses. When skin cancer becomes locally advanced or spreads to other organs, the symptom profile broadens considerably. Common sites for metastasis include the lungs, liver, bone, and distant skin sites.18PubMed. Symptoms of and Palliative Treatment for Unresectable Skin Cancer Pain is often the first systemic symptom, frequently related to bone metastases. Shortness of breath can signal lung involvement. Loss of appetite and unintentional weight loss are common as the disease burden grows.
At the primary tumor site, advanced cancers can cause bleeding, wound drainage, and a persistent foul smell from ulcerated tissue. These are characteristic of skin cancers specifically, as opposed to internal malignancies, and they significantly affect quality of life.19PubMed. Symptom prevalence in patients with advanced skin cancer Bleeding from a skin lesion doesn’t automatically mean advanced cancer. BCC and SCC can bleed early on simply because they’re fragile. But a lesion that bleeds repeatedly, produces discharge, or develops an odor should be evaluated promptly.
How Reliable Is Self-Examination
Monthly skin self-exams are widely recommended, and they do catch cancers. But their accuracy is more limited than most people assume. In a diagnostic accuracy study of high-risk patients, self-detection had a sensitivity of about 69% for basal cell carcinoma and roughly 62% for melanoma, meaning about a third of BCCs and nearly 40% of melanomas were missed by the patients themselves.20PubMed. Self-skin Examination for Skin Cancer Detection in High-risk Populations: A Diagnostic Accuracy Study and Implications for Cancer Education Specificity was also low, around 44-47%, meaning many benign lesions caused unnecessary worry.
These numbers aren’t an argument against self-exams. They’re an argument for pairing them with professional skin checks, especially if you have risk factors like a history of sunburns, fair skin, many moles, a family history of melanoma, or immunosuppression. Self-exams work best as an early-alert system. You’re the only person who sees your skin every day, and you’re the one most likely to notice when something new appears or an old mole changes. The professional exam fills in the gaps, catching the subtle or atypical lesions that untrained eyes tend to miss.
Smartphone apps that analyze photos of moles have entered the market, but current evidence suggests caution. A prospective study of a CE-certified screening app found that it significantly over-detected suspicious lesions while still performing poorly compared to dermatologists. The researchers concluded that apps might increase awareness but cautioned against relying on them for actual diagnosis, noting potential harm from both false alarms and false reassurance.21PubMed Central. Over-Detection of Melanoma-Suspect Lesions by a CE-Certified Smartphone App: Performance in Comparison to Dermatologists, 2D and 3D Convolutional Neural Networks in a Prospective Data Set of 1204 Pigmented Skin Lesions Involving Patients’ Perception
What Dermoscopy Adds to the Clinical Exam
Dermoscopy, a technique where a clinician uses a handheld magnifying device with polarized light to examine a lesion’s structure beneath the skin surface, has become a standard tool in dermatology offices. Multiple studies have confirmed that it improves both sensitivity and specificity for skin cancer detection compared with looking at a lesion with the naked eye alone.22PubMed. Usefulness of dermoscopy to improve the clinical and histopathologic diagnosis of skin cancers It’s especially valuable for catching thinner, smaller cancers at an earlier stage and for reducing unnecessary biopsies by helping clinicians distinguish benign spots from suspicious ones more confidently.22PubMed. Usefulness of dermoscopy to improve the clinical and histopathologic diagnosis of skin cancers
The device reveals structures invisible to the unaided eye: pigment networks, vascular patterns, and color distributions that correspond to specific diagnoses. For amelanotic melanomas, where the naked eye sees only an ambiguous pink bump, dermoscopy can pick up irregular blood vessel arrangements and structureless white zones that point toward malignancy.7PubMed. Clinicopathological and dermoscopic features of amelanotic and hypomelanotic melanoma: a retrospective multicentric study For suspicious pink lesions in general, advanced imaging techniques like reflectance confocal microscopy can provide near-cellular-level resolution without a biopsy, though this technology remains limited to specialized centers.23PubMed. The significance of reflectance confocal microscopy in the assessment of solitary pink skin lesions
If your dermatologist pulls out a dermoscope during a skin check, that’s a good sign that they’re practicing evidence-based medicine. And if you have a lesion that’s been brushed off as benign by visual inspection alone, asking whether dermoscopy has been used is a reasonable question. The technology is not exotic or expensive; it’s simply a more thorough way of looking at skin.
Transplant Recipients and the Immunosuppressed
People taking immunosuppressive medications, particularly organ transplant recipients, face a dramatically elevated risk of skin cancer. Squamous cell carcinoma is the most disproportionately affected type, and transplant recipients develop SCCs at rates far exceeding the general population. The biology behind this goes beyond simple immune surveillance failure. Calcineurin inhibitors, the class of drugs that includes the widely used transplant medications cyclosporine and tacrolimus, directly impair skin cells’ ability to repair UV-induced DNA damage by reducing the activity of key DNA repair genes.17PubMed Central. Skin cancer in organ transplant recipients: more than the immune system The result is a double hit: the immune system is less able to detect cancer cells, and the skin cells accumulate more mutations from sun exposure.
For transplant recipients, dermatological surveillance isn’t optional. Skin exams every six to twelve months are standard care, and any new or changing lesion should be evaluated promptly. The warning signs are the same as for anyone else, but the threshold for concern is lower, and the speed at which a suspicious spot should be biopsied is faster. SCCs in transplant patients also tend to be more aggressive, with a higher rate of recurrence and metastasis than the same cancer in immunocompetent patients. If you’re on long-term immunosuppression for any reason, not just transplant, discuss a skin-monitoring schedule with your care team.